• Contact
Tuesday, May 20, 2025
Register
Login
European Press
Advertisement
  • News
  • Business
  • Tech
  • Sport
  • Health
  • Entertainment
  • Lifestyle
  • Video
No Result
View All Result
  • News
  • Business
  • Tech
  • Sport
  • Health
  • Entertainment
  • Lifestyle
  • Video
No Result
View All Result
European Press
No Result
View All Result

Flatiron Health, Massive Bio partner to improve clinical trial access

8 April 2025
in Health
Reading Time: 3 mins read
A A
Flatiron Health, Massive Bio partner to improve clinical trial access
ShareShareShareShareShare


Oncology-focused digital health company Flatiron Health announced it entered into a strategic partnership with Massive Bio, a company that helps cancer patients find and enroll in clinical trials.
Flatiron Health is an oncology-focused health technology company that offers a platform aimed at optimizing the clinical trial process, including selecting trial sites and identifying patients who are eligible for trials. The company also provides electronic health record services and clinical decision support tools to providers. 
Massive Bio uses AI to identify cancer patients eligible for clinical trials and connect them and their doctors to applicable trials.
Flatiron will use Massive Bio’s database on a per-study basis to find patients who are not enrolled in clinical trials but live close to a trial site.
Those patients will then be directed to one of Flatiron’s research sites, where they can be brought on as new patients and possibly enrolled in a clinical trial utilizing Flatiron’s proprietary technology and consolidated patient identification services.
“Flatiron Health is excited to join forces with Massive Bio, combining expertise and resources to advance personalized treatment options for cancer patients,” Michael Bierl, vice president of clinical research partnerships and general manager Europe at Flatiron Health, said in a statement.
“By leveraging Massive Bio’s robust network and database, we can continue to utilize our cutting-edge tools to empower sites to progress research, enhance workflows and efficiencies, accelerate clinical trace pace while ensuring diverse patient populations have access to life-changing treatments that might otherwise be out of reach.”
Arturo Loaiza-Bonilla, cofounder and chief medical officer at Massive Bio, said the company’s mission is to make access to clinical trials patient-centric and guarantee the right patient is matched to the right trial at the right time, regardless of where they live. 
“By pairing our AI-driven platform and concierge services with Flatiron Health’s extensive research infrastructure, we can help physicians and care teams expedite trial enrollment, reduce disparities in access and improve outcomes for more patients,” Loaiza-Bonilla said in a statement. 
THE LARGER TREND
In March, the University of Colorado Cancer Center (CU Cancer Center) and Flatiron Health joined forces to make clinical trials more productive by lowering the administrative burden for researchers.
The partnership brought Flatiron Clinical Pipe to the CU Cancer Center and UCHealth, which allowed clinical trial data to move directly from electronic health records to electronic data capture systems. The technology also transfers information directly from the EHR to trial databases.
Flatiron Clinical Pipe is an electronic health record to electronic data capture connector that captures and transfers trial data.
That same month, Flatiron collaborated with NRG Oncology, a clinical research consortium in the National Cancer Institute’s National Clinical Trials Network, to use Flatiron Clinical Pipe in a multicenter NRG clinical trial. 
In February, Flatiron partnered with Exact Sciences to increase clinical evidence generation for Exact Sciences’ molecular residual disease test Oncodetect. The alliance utilizes Flatiron’s clinical research platform to evaluate a wide range of solid tumor types. 
The aim was to gather clinical evidence in a real-world setting and disparate patient populations by using community care settings that are generally underrepresented in clinical trials. 
In January, DeepScribe partnered with Flatiron to bring DeepScribe’s AI documentation to clinicians who use Flatiron’s OncoEMR, a cloud-based electronic medical record platform.
The alliance made DeepScribe the first ambient AI solution partner for Flatiron Health.
Last year, Flatiron collaborated with the Association of Cancer Care Centers (ACCC) to promote access to clinical trials in a community setting, boost clinical study efficiency and increase the collection of study-related data. 
In 2022, Massive Bio secured $9 million in financing. Revo Capital and Kenan Turnacioğlu led the round, with participation from DEG. The company used the funds to grow its operations globally, market itself and launch new products.
 

Credit: Source link

Related Posts:

  • Flatiron Health, Massive Bio partner to improve clinical trial access
    Flatiron Health, Massive Bio partner to improve…
  • Flatiron, National Cancer Institute announce partnership and more digital health news
    Flatiron, National Cancer Institute announce…
  • Evinova, Quantum Leap Healthcare Collaborative announce partnership
    Evinova, Quantum Leap Healthcare Collaborative…
  • Digital twin company Unlearn partners with Trace Neuroscience
    Digital twin company Unlearn partners with Trace…
ShareTweetSendPinShare
Previous Post

Jobless rate drops to 2-month low

Next Post

Celebrity Big Brother’s Michael Fabricant addresses confusion over his hair

Next Post
Celebrity Big Brother’s Michael Fabricant addresses confusion over his hair

Celebrity Big Brother’s Michael Fabricant addresses confusion over his hair

Recommended

Remittance growth hits 9-month low

Remittance growth hits 9-month low

15 May 2025
Latest news bulletin | May 1st – Evening

Latest news bulletin | May 1st – Evening

15 May 2025
Slate truck revealed: See the K customizable electric truck for 2026

Slate truck revealed: See the $28K customizable electric truck for 2026

25 April 2025
Carta Healthcare raises .25M to expand AI clinical data platform

Carta Healthcare raises $18.25M to expand AI clinical data platform

7 May 2025
Meloni: ‘Sala’s release made my day — and I didn’t talk to Musk about Starlink’

Meloni: ‘Sala’s release made my day — and I didn’t talk to Musk about Starlink’

28 April 2025
European Press

European-press.com shares the latest news from Europe and around the world. It covers topics such as business, technology, sports, health, entertainment, and lifestyle. Feel free to get in touch with us!

Disclaimer  Privacy Policy – EU  Imprint 

Contact Us

What’s New Here!

  • Pope Leo XIV hosts first audience with the press at the Vatican
  • Islanders have window for a double-dose of Maple Leafs revenge
  • How your body can tell if you’re with the wrong partner
  • First look as Jason Grimshaw returns to Weatherfield

Subscribe to Our Newsletter

Copyright 2025 © EUROPEAN PRESS All rights on our posts reserved!

Translate »
European Press
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}
No Result
View All Result
  • News
  • Business
  • Tech
  • Sport
  • Health
  • Entertainment
  • Lifestyle
  • Video

Copyright 2025 © EUROPEAN PRESS All rights on our posts reserved!

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?
×